"/> Novus Biologicals™ Peptide bloquant d’anticorps MA… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps MAVS

Réf. : BL-RE-084813Réf. fabricant : 18257885 0.05 mg
201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
57506
Espèces
Human
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NBP1-77275. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

A blocking peptide containing 13 amino acids near the carboxy terminus of human VISA.

Points forts

Source

Synthetic

(Accession #: NP_065797) The MAVS Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-084813
Réf. fabricant18257885
Gene ID (Entrez)57506
EspècesHuman
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-77275. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gèneCARD adapter inducing interferon beta, CARD adapter inducing interferon-beta, CARD adaptor inducing IFN-beta, CARDIF, DKFZp547C224, DKFZp666M015, FLJ27482, IFN-B promoter stimulator 1, Interferon beta promoter stimulator protein 1, interferon-beta promoter stimulator protein 1, IPS-1 FLJ41962, IPS1MGC3260, KIAA1271FLJ35386, mitochondrial antiviral signaling protein, mitochondrial antiviral-signaling protein, mitochondrial viral signaling protein, Putative NF-kappa-B-activating protein 031 N, virus-induced signaling adapter variant 1 b, virus-induced signaling adaptor variant 1 A, Virus-induced-signaling adapter, VISAFLJ38051
Symbole de gène(s)MAVS
Type de produitMAVS
Quantité0.05 mg
État réglementaireRUO - research use only
SourceSynthetic
Consigne13 amino acids near the carboxy terminus of human VISA
Une question, une configuration particulière ?
Contactez-nous pour un devis.